Approvals/TGA/FLUCLOXACILLIN KABI flucloxacillin 500 mg (as sodium) powder for injection vial

Approved

STANDARD

FLUCLOXACILLIN KABI flucloxacillin 500 mg (as sodium) powder for injection vial

Fresenius Kabi Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 898dc1d66444949c
Product Name: FLUCLOXACILLIN KABI flucloxacillin 500 mg (as sodium) powder for injection vial
Artg Id: 340130
Artg Name: FLUCLOXACILLIN KABI flucloxacillin 500 mg (as sodium) powder for injection vial
Sponsor: Fresenius Kabi Australia Pty Ltd
Company Detail Path: /organization/fresenius-kabi-australia-pty-ltd
Artg Date: 2021-06-07
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/ecfd4f0c2873cabccd25f1db9c3a381b.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/e423ae42e7b2ef195a1161a6f5856a56.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

898dc1d66444949c

Type

Standard